S100B-immunopositive astrocytes and oligodendrocytes in the hippocampus are differentially afflicted in unipolar and bipolar depression: A postmortem study

Journal of Psychiatric Research

Volumn 47, Issue 11, 2013, Pages 1694-1699

  Gos, Tomasz ^a,b   Schroeter, Matthias L ^c,d   Lessel, Wiebke ^a   Bernstein, Hans Gert ^a   Dobrowolny, Henrik ^a   Schiltz, Kolja ^a,e   Bogerts, Bernhard ^a,e   Steiner, Johann ^a,e  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e Center for Behavioral Brain Sciences   (Germany)

Author keywords

Bipolar disorder; Depression; Histopathology; Major depressive disorder; Postmortem; S 100B; S100 beta; S100B

Indexed keywords

PROTEIN S100B;

ADULT; ARTICLE; ASTROCYTE; AUTOPSY; BIPOLAR DEPRESSION; CAUSE OF DEATH; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DSM-IV; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR DEPRESSION; MALE; OLIGODENDROGLIA; PRIORITY JOURNAL;

BIPOLAR DISORDER; DEPRESSION; HISTOPATHOLOGY; MAJOR DEPRESSIVE DISORDER; POSTMORTEM; S-100B; S100 BETA; S100B;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; ASTROCYTES; BIPOLAR DISORDER; CELL COUNT; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; OLIGODENDROGLIA; POSTMORTEM CHANGES; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT;

EID: 84884417192     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2013.07.005     Document Type: Article

References (41)

1. Adami C., Bianchi R., Pula G., Donato R. S100B-stimulated NO production by BV-2 microglia is independent of RAGE transducing activity but dependent on RAGE extracellular domain. Biochimica et Biophysica Acta 2004, 1742:169-177.
2. Akhisaroglu M., Manev R., Akhisaroglu E., Uz T., Manev H. Both aging and chronic fluoxetine increase S100B content in the mouse hippocampus. Neuroreport 2003, 14:1471-1473.
3. Almeida J.R., Versace A., Mechelli A., Hassel S., Quevedo K., Kupfer D.J., Phillips M.L. Abnormal amygdala-prefrontal effective connectivity to happy faces differentiates bipolar from major depression. Biological Psychiatry 2009, 66:451-459.
4. Aston C., Jiang L., Sokolov B.P. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Molecular Psychiatry 2005, 10:309-322.
5. Bianchi R., Adami C., Giambanco I., Donato R. S100B binding to RAGE in microglia stimulates COX-2 expression. Journal of Leukocyte Biology 2007, 81:108-118.
6. Cocchia D., Michetti F., Donato R. Immunochemical and immuno-cytochemical localization of S-100 antigen in normal human skin. Nature 1981, 294:85-87.
7. Dean B., Gray L., Scarr E. Regionally specific changes in levels of cortical S100beta in bipolar 1 disorder but not schizophrenia. Australian and New Zealand Journal of Psychiatry 2006, 40:217-224.
8. Deloulme J.C., Raponi E., Gentil B.J., Bertacchi N., Marks A., Labourdette G., Baudier J. Nuclear expression of S100B in oligodendrocyte progenitor cells correlates with differentiation toward the oligodendroglial lineage and modulates oligodendrocytes maturation. Molecular and Cellular Neuroscience 2004, 27:453-465.
9. Donato R., Sorci G., Riuzzi F., Arcuri C., Bianchi R., Brozzi F., Tubaro C., Giambanco I. S100B's double life: intracellular regulator and extracellular signal. Biochimica et Biophysica Acta 2009, 1793:1008-1022.
10. Femenia T., Gomez-Galan M., Lindskog M., Magara S. Dysfunctional hippocampal activity affects emotion and cognition in mood disorders. Brain Research 2012, 1476:58-70.
11. Goncalves C.A., Leite M.C., Nardin P. Biological and methodological features of the measurement of S100B, a putative marker of brain injury. Clinical Biochemistry 2008, 41:755-763.
12. Grabe H.J., Ahrens N., Rose H.J., Kessler C., Freyberger H.J. Neurotrophic factor S100 beta in major depression. Neuropsychobiology 2001, 44:88-90.
13. Haring J.H., Hagan A., Olson J., Rodgers B. Hippocampal serotonin levels influence the expression of S100 beta detected by immunocytochemistry. Brain Research 1993, 631:119-123.
14. Hsu S.M., Soban E. Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry. Journal of Histochemistry and Cytochemistry 1982, 30:1079-1082.
15. Mai J.K., Assheuer J., Paxinos G. Atlas of the human brain 2003, Academic Press, San Diego. 2nd ed.
16. Michetti F., Dell'Anna E., Tiberio G., Cocchia D. Immunochemical and immunocytochemical study of S-100 protein in rat adipocytes. Brain Research 1983, 262:352-356.
17. Moore B.W. Asoluble protein characteristic of the nervous system. Biochemical and Biophysical Research Communications 1965, 19:739-744.
18. Muller M.B., Lucassen P.J., Yassouridis A., Hoogendijk W.J., Holsboer F., Swaab D.F. Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. European Journal of Neuroscience 2001, 14:1603-1612.
19. Polak M., Haymaker W., Johnson J.E., DD́Amelio F. Neuroglia and their reactions. Histology and histopathology of the nervous system 1982, 363-480. Charles C. Thomas Publishing, Springfield. W. Haymaker, R.D. Adams (Eds.).
20. Rajkowska G., Miguel-Hidalgo J.J. Gliogenesis and glial pathology in depression. CNS & Neurological Disorders - Drug Targets 2007, 6:219-233.
21. Regenold W.T., Phatak P., Marano C.M., Gearhart L., Viens C.H., Hisley K.C. Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and unipolar major depression. Psychiatry Research 2007, 151:179-188.
22. Reiber H. Dynamics of brain-derived proteins in cerebrospinal fluid. Clinica Chimica Acta 2001, 310:173-186.
23. Reiber H. Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics. Restorative Neurology and Neuroscience 2003, 21:79-96.
24. Rong H., Wang G., Liu T., Wang H., Wan Q., Weng S. Chronic mild stress induces fluoxetine-reversible decreases in hippocampal and cerebrospinal fluid levels of the neurotrophic factor S100B and its specific receptor. International Journal of Molecular Sciences 2010, 11:5310-5322.
25. Rothermundt M., Arolt V., Wiesmann M., Missler U., Peters M., Rudolf S., et al. S-100B is increased in melancholic but not in non-melancholic major depression. Journal of Affective Disorders 2001, 66:89-93.
26. Schmitt A., Steyskal C., Bernstein H.G., Schneider-Axmann T., Parlapani E., Schaeffer E.L., et al. Stereologic investigation of the posterior part of the hippocampus in schizophrenia. Acta Neuropathology 2009, 117:395-407.
27. Schroeter M.L., Abdul-Khaliq H., Krebs M., Diefenbacher A., Blasig I.E. Serum markers support disease-specific glial pathology in major depression. Journal of Affective Disorders 2008, 111:271-280.
28. Schroeter M.L., Abdul-Khaliq H., Sacher J., Steiner J., Blasig I.E., Mueller K. Mood disorders are glial disorders: evidence from invivo studies. Cardiovascular Psychiatry and Neurology 2010, Article ID 780645: 7 pages.
29. Schroeter M.L., Steiner J. Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders. Molecular Psychiatry 2009, 14:235-237.
30. Small S.A., Schobel S.A., Buxton R.B., Witter M.P., Barnes C.A. Apathophysiological framework of hippocampal dysfunction in ageing and disease. Nature Reviews Neuroscience 2011, 12:585-601.
31. Stefansson K., Wollmann R.L., Moore B.W. Distribution of S-100 protein outside the central nervous system. Brain Research 1982, 234:309-317.
32. Steiner J., Bernstein H.G., Bielau H., Berndt A., Brisch R., Mawrin C., Keilhoff G., Bogerts B. Evidence for a wide extra-astrocytic distribution of S100B in human brain. BMC Neuroscience 2007, 8:2. (10 pages).
33. Steiner J., Bernstein H.G., Bielau H., Farkas N., Winter J., Dobrowolny H., Brisch R., Gos T., Mawrin C., Myint A.M., Bogerts B. S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study. Journal of Psychiatric Research 2008, 42:868-876.
34. Steiner J., Bernstein H.G., Bogerts B., Goncalves C.A. Potential roles of S100B in schizophrenia. Revista de Psiquiatria Clínica 2013, 40:35-40.
35. Steiner J., Bielau H., Brisch R., Danos P., Ullrich O., Mawrin C., Bernstein H.G., Bogerts B. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. Journal of Psychiatric Research 2008, 42:151-157.
36. Steiner J., Marquardt N., Pauls I., Schiltz K., Rahmoune H., Bahn S., Bogerts B., Schmidt R.E., Jacobs R. Human CD8(+) T cells and NK cells express and secrete S100B upon stimulation. Brain, Behavior, and Immunity 2011, 25:1233-1241.
37. Steiner J., Walter M., Gos T., Guillemin G.J., Bernstein H.G., Sarnyai Z., Mawrin C., Brisch R., Bielau H., Meyer zu Schwabedissen L., Bogerts B., Myint A.M. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?. Journal of Neuroinflammation 2011, 8:94.
38. Steiner J., Westphal S., Schroeter M.L., Schiltz K., Jordan W., Muller U.J., et al. Increased S100B+ NK cell counts in acutely ill schizophrenia patients are correlated with the free cortisol index, but not with S100B serum levels. Brain Behav Immun. 2012, 26:564-567.
39. Tramontina A.C., Tramontina F., Bobermin L.D., Zanotto C., Souza D.F., Leite M.C., Nardin P., Gottfried C., Goncalves C.A. Secretion of S100B, an astrocyte-derived neurotrophic protein, is stimulated by fluoxetine via a mechanism independent of serotonin. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2008, 32:1580-1583.
40. Uranova N.A., Vostrikov V.M., Orlovskaya D.D., Rachmanova V.I. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophrenia Research 2004, 67:269-275.
41. van Eldik L.J., Wainwright M.S. The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restorative Neurology and Neuroscience 2003, 21:97-108.